Bone marrow stem cell therapy for stroke

This book covers recent advances in all aspects of bone marrow-derived stem cells (BMSCs) for stroke treatment, while also providing comprehensive information on human clinical trials and animal models of stroke. In addition, it reviews the optimal conditions of transplantation for stroke therapy an...

Full description

Saved in:
Bibliographic Details
Other Authors: Jin, Kunlin, (Editor), Ji, Xunming, (Editor), Zhuge, Qichuan, (Editor)
Format: eBook
Language: English
Published: Singapore : Springer, 2017.
Subjects:
ISBN: 9789811029295
9789811029288
Physical Description: 1 online resource

Cover

Table of contents

LEADER 05493cam a2200481Ii 4500
001 97121
003 CZ-ZlUTB
005 20240914110346.0
006 m o d
007 cr cnu|||unuuu
008 161216s2017 si ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d GW5XE  |d IDEBK  |d EBLCP  |d YDX  |d OCLCF  |d N$T  |d AZU  |d UAB  |d COO  |d MERUC  |d UPM  |d IOG  |d VT2  |d ESU  |d JBG  |d IAD  |d ICW  |d ICN  |d OTZ  |d OCLCQ  |d U3W  |d CAUOI  |d UWW  |d AU@  |d OCLCQ  |d WYU  |d UKMGB  |d OCLCQ 
020 |a 9789811029295  |q (electronic bk.) 
020 |z 9789811029288 
024 7 |a 10.1007/978-981-10-2929-5  |2 doi 
035 |a (OCoLC)966313039  |z (OCoLC)966551741  |z (OCoLC)974650155  |z (OCoLC)981089868  |z (OCoLC)1005774083  |z (OCoLC)1011959674  |z (OCoLC)1048139631  |z (OCoLC)1058291074  |z (OCoLC)1066463687 
245 0 0 |a Bone marrow stem cell therapy for stroke /  |c Kunlin Jin, Xunming Ji, Qichuan Zhuge, editors. 
264 1 |a Singapore :  |b Springer,  |c 2017. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
505 0 |a Dedication; Preface; Contents; Contributors; Chapter 1: Ischemic Stroke Pathophysiology and Cell Therapy; 1.1 Introduction; 1.2 Pathophysiology of Ischemic Stroke; 1.2.1 Thrombosis; 1.2.2 Embolism; 1.2.3 Systemic Hypoperfusion; 1.2.4 Cellular Pathophysiology; 1.2.5 Cell Death After Stroke; 1.2.6 Mechanisms of Necrotic Cell Death; 1.2.7 Mechanisms of Programmed Cell Death; 1.3 Types of Stem Cells Used in Experimental Ischemic Stroke Therapy; 1.3.1 Embryonic Stem Cells (ESCs); 1.3.2 Mesenchymal Stem Cells (MSCs); 1.3.3 Bone Marrow-Derived MSCs (BMSCs). 
505 8 |a 1.3.4 Adipose-Derived Mesenchymal Stem Cells (AD-MSCs)1.3.5 Placenta-Derived Mesenchymal Stem Cells (PD-MSCs); 1.3.6 Induced Pluripotent Stem Cells (iPSCs); 1.3.6.1 Cell Therapy Using iPSCs for Stroke; 1.3.6.2 Mechanism of iPSC Therapy in Stroke; 1.3.7 Endothelial Progenitor Cells (EPCs); 1.3.7.1 Mechanism of EPC Therapy in Stroke; 1.3.8 Neural Stem Cells; 1.3.8.1 The Attempts to Treat Stroke with NSCs; 1.3.8.2 Underlying Mechanisms; References; Chapter 2: Bone Marrow Stem Cells: Source, Characterization, Isolation, Culture, and Identification; 2.1 Introduction; 2.2 Source. 
505 8 |a 2.2.1 Mesenchymal Stem Cells2.2.2 Hematopoietic Stem Cells; 2.2.3 Endothelial Progenitor Cells; 2.3 Characterization and Identification; 2.3.1 MSCs; 2.3.1.1 Morphology and Cell Cycle Study; 2.3.1.2 Differentiation Capacity; 2.3.1.3 Function; 2.3.1.4 Phenotype and Identification; 2.3.2 HSCs; 2.3.2.1 Multipotency; 2.3.2.2 Self-Renewal; 2.3.2.3 Markers and Identification; 2.3.3 EPCs; 2.3.3.1 Regenerative Potential of EPCs; 2.3.3.2 Phenotype and Identification; 2.4 Isolation; 2.4.1 MSCs; 2.4.2 HSCs; 2.4.3 EPCs; 2.5 Culture; 2.5.1 MSCs; 2.5.2 EPCs; 2.6 Conclusion; References. 
505 8 |a Chapter 3: Mobilization and Homing of Bone Marrow Stem Cells After Stroke3.1 Introduction; 3.2 Bone Mesenchymal Stem Cells; 3.2.1 The Characterization of BMSCs; 3.2.2 BMSC Mobilization After Stroke; 3.2.3 The Potential Signaling Pathway/Mechanisms Underlying BMSC Homing; 3.2.3.1 MCP-1; 3.2.3.2 CD44 and Selectin; 3.2.4 BMSCs Induced Neurotrophic Factor Secretion and Restoration of Neural Function; 3.3 Bone Marrow-Derived Hematopoietic Stem Cells; 3.3.1 The Characterization of HSCs and the Niches; 3.3.1.1 The Characterization of HSCs; 3.3.1.2 The HSC Niches; 3.3.2 HSC Mobilization After Stroke. 
505 8 |a 3.3.2.1 Mechanisms of HSPC Mobilization After Stroke3.3.2.1.1 The SDF-1/CXCR4 Interaction; 3.3.2.1.2 Interplays of the Sympathetic Nervous System with SDF-1/CXCR4 and G-CSF; 3.3.2.2 Agents That Enhance the Mobilization of HSCs for Stroke; 3.3.3 HSC Homing to the Ischemic Brain; 3.3.3.1 Mechanisms of HSC Homing After Stroke; 3.3.3.2 Methods of Enhancing HSC Homing to Ischemic Brain; 3.3.4 Regulations of HSC on Neural Restoration and Neural Function After Stroke; 3.4 Bone Marrow-Derived Endothelial Progenitor Cells; 3.4.1 Characteristics of EPCs; 3.4.1.1 EPCs and Angiogenesis. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This book covers recent advances in all aspects of bone marrow-derived stem cells (BMSCs) for stroke treatment, while also providing comprehensive information on human clinical trials and animal models of stroke. In addition, it reviews the optimal conditions of transplantation for stroke therapy and potential mechanisms underlying transplanted cell-mediated functional recovery after stroke. As the first book to focus on BMSC therapy for stroke, it also discusses in depth the unique challenges of BMSCs-based therapy in this context. 
504 |a Includes bibliographical references and index. 
590 |a SpringerLink  |b Springer Complete eBooks 
650 0 |a Mesenchymal stem cells. 
650 0 |a Cerebrovascular disease  |x Treatment. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Jin, Kunlin,  |e editor. 
700 1 |a Ji, Xunming,  |e editor. 
700 1 |a Zhuge, Qichuan,  |e editor. 
776 0 8 |i Print version:  |t Bone marrow stem cell therapy for stroke.  |d Singapore : Springer, 2017  |z 9811029288  |z 9789811029288  |w (OCoLC)959034864 
856 4 0 |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-981-10-2929-5  |y Plný text 
992 |c NTK-SpringerBLS 
999 |c 97121  |d 97121 
993 |x NEPOSILAT  |y EIZ